Wells Fargo’s Nexalin Technology NXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$348 Buy
+1,000
New +$521 ﹤0.01% 6425
2025
Q2
Sell
-600
Closed -$1.17K 7297
2025
Q1
$1.17K Hold
600
﹤0.01% 6224
2024
Q4
$1.66K Buy
+600
New +$1.67K ﹤0.01% 6209
2024
Q2
Sell
-44
Closed -$62 7294
2024
Q1
$62 Buy
44
+1
+2% ﹤0.01% 6777
2023
Q4
$17 Buy
43
+1
+2% ﹤0.01% 7262
2023
Q3
$18 Buy
42
+25
+147% +$16 ﹤0.01% 7238
2023
Q2
$15 Buy
17
+1
+6% +$1 ﹤0.01% 7367
2023
Q1
$13 Hold
16
﹤0.01% 7466
2022
Q4
$12 Buy
+16
New +$25 ﹤0.01% 7364

Other funds holding NXL

Wells Fargo's NXL Position: Q1 2026 in Review

Wells Fargo opened a new position in Nexalin Technology (NXL) in Q1 2026: 1,000 shares worth $348. The stake represents ﹤0.01% of the portfolio and ranks #6425 among its holdings. This is a return to the name: Wells Fargo previously reported a position in NXL as recently as Q1 2025.

Wells Fargo first reported a position in NXL in Q4 2022 and has held it in 9 quarters since. The position peaked at $1.66K in Q4 2024. 23 funds tracked by Wall St. Rank hold NXL as of Q1 2026.

  • Wells Fargo held 1,000 shares of Nexalin Technology worth $348 as of Q1 2026.
  • Nexalin Technology was a new Wells Fargo position in Q1 2026.
  • Nexalin Technology made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6425 holding.
  • Wells Fargo first reported a position in Nexalin Technology in Q4 2022 and has held it in 9 quarters since.
  • Wells Fargo's Nexalin Technology position peaked at $1.66K in Q4 2024.
  • 23 funds tracked by Wall St. Rank held Nexalin Technology as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.